Omada Health raises margin targets; Barclays lifts price target
Omada Health raised long-term targets, including gross margin to 80% and adjusted EBITDA margin to 30%. Barclays maintained an Overweight rating and lifted its price target to $27.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.